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INTRODUCTION
Kaposi sarcoma herpes virus (KSHV), also known as human
herpesvirus-8 (HHV-8), is a gamma 2 herpesvirus or rhadi-
novirus. The target cells of KSHV are relatively broad, and
include B and T lymphocytes, endothelial cells, and subsets
of monocytes and macrophages (1). It is well-known that K-
SHV is associated with Kaposi sarcoma (KS), multicentric
Castleman disease (MCD; pathologically, the plasma cell vari-
ant), and primary effusion lymphoma (1). KSHV has been
detected in 40-50% of HIV-negative patients with MCD,
and in nearly all HIV-positive patients with MCD (2). KSHV-
positive Castleman disease has its unique histopathologic fea-
tures owing to the accumulation of virus-infected lympho-
cytes in the mantle zone, which result in progressive follicu-
lar lysis and up-regulation of low affinity nerve growth factor
receptor in the stroma around the regressed lymphoid folli-
cles (3). According to recent reports, KSHV is rarely related
to the hemophagocytic syndrome, mostly in immunocom-
promised hosts, such as HIV-positive or transplantation pati-
ents (4, 5). However, KSHV-associated hemophagocytic syn-
drome has also been described in a HIV-negative, immuno-
competent patient with the plasmablastic variant of MCD
(plasmablastic microlymphoma) (6). Herein, we provide ano-
ther example of KSHV-associated hemophagocytic syndrome
concomitant with KS and Castleman disease of the plasma
cell type in a HIV-negative, immunocompetent patient.
CASE REPORT
Clinical history
A 62-yr-old male patient was referred to the Department
of Oncology due to a leukocytopenia, anemia and splenome-
galy, which was discovered during the evaluation of three-ves-
sel heart disease. He had hypertension, chronic alcoholism,
was an ex-smoker, and had diabetes mellitus, which had been
detected three months previously. There was no history sug-
gesting immune deficiency. The HIV ELISA test was nega-
tive. Laboratory data revealed leukocytopenia and anemia
(WBC, 1.98×103/μ L; Hb, 9.8 g/dL; and platelets, 166×
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Kaposi Sarcoma Herpes Virus-associated Hemophagocytic Syndrome
Complicated by Multicentric Castleman Disease and Kaposi Sarcoma
in a HIV-negative Immunocompetent Patient: An Autopsy Case
Kaposi sarcoma herpes virus (KSHV), also known as human herpesvirus-8, plays
an important role in the pathogenesis of Kaposi sarcoma (KS), multicentric Castle-
man disease (MCD) of the plasma cell type, and primary effusion lymphoma. KSHV
is rarely associated with the hemophagocytic syndrome (HPS), but when it does occur,
it most occurs in immunocompromised patients. We report herein an unusual case
of KSHV-associated HPS in an immunocompetent patient. A previously healthy 62-
yr-old male was referred for evaluation of leukocytopenia and multiple lymphadeno-
pathies. After a lymph node biopsy, he was diagnosed with MCD of the plasma cell
type. KSHV DNA was detected in the lymph node tissue by polymerase chain reac-
tion. Following a short-term response of the leukocytopenia to prednisolone, men-
tal change, left side weakness, fever, thrombocytopenia, hemolytic anemia, and
renal failure developed. Despite intravenous immunoglobulin therapy and plasma-
pheresis, he expired. The lymph nodes were infiltrated by hemophagocytic histio-
cytes in the sinuses. Pulmonary nodules and gastric erosions were shown to be
KS. KSHV DNA was detected in the stomach, lung, and liver. This is the first case
of multiple KSHV associated diseases including MCD and KS with KSHV-associ-
ated hemophagocytic syndrome in an HIV-negative, non-transplant, immunocom-
petent patient.
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103/μ L). The blood glucose level was normal (101 mg/dL).
An abdominal and chest computerized tomography revealed
splenomegaly and multiple lymphadenopathies in the medi-
astinum, axilla, abdomen, and pelvic cavity. After excisional
biopsy of a left submental lymph node, he was diagnosed with
Castleman disease of the plasma cell type. A bone marrow
biopsy was interpreted as a T cell lymphoproliferative disor-
der. He was discharged after prednisolone treatment. How-
ever, he returned to the emergency room nine days later be-
cause of altered mental status, fever, and left side weakness.
The laboratory data obtained in the emergency department
was significant for severe thrombocytopenia (WBC, 5.50×
103/μ L; Hb, 9.8 g/dL; and platelets, 21×103/μ L) and an ele-
vated blood urea nitrogen level (36 mg/dL). Brain magnetic
resonance image revealed a multifocal acute ischemic infarc-
tion in the right cerebral hemisphere. A peripheral blood sme-
ar displayed a few atypical plasmacytoid lymphocytes. A dis-
integrin and metalloproteinase with thrombospondin type
(ADAMTS) 13 and von Willebrand factor (VWF) cleaving
protease (cp) were within normal limits (46.93%). The IL-6
level was not evaluated. There was no evidence of infection
based on urine culture and respiratory examination. Although
schistocytes were not detected in the peripheral blood smear
findings, the sudden neurological deficits, severe thrombo-
cytopenia with immune hemolytic anemia, fever, and renal
failure together were suggestive of thrombotic thrombocy-
topenic purpura (TTP), therefore, plasmapheresis and intra-
venous immunoglobulin treatment were initiated. Howev-
er, thrombocytopenia was aggravated (platelet, 10×103/μ L)
and the urine output decreased to 600 cc with elevation of
the BUN/Cr level to 165/2.4 mg/dL. The D-dimer was 3.60
μ g/mL and the fibrin degradation products were positive (1:
20). Total and direct bilirubin levels were 28.6 mg/dL and
20.0 mg/dL, respectively. He expired with acute renal fail-
ure, disseminated intravascular coagulation, and pulmonary
edema. 
Pathologic diagnosis and autopsy findings
Excisional biopsy of a submentaI lymph node revealed mix-
ed hyperplastic and atrophic lymphoid follicles with a con-
centric layering of lymphocytes in the mantle zone (Fig. 1A).
Numerous plasma cells were aggregated in sheets in the inter-
follicular area with scattered large CD30 (Ki-1) positive im-
munoblastic cells (Fig. 1B). KSHV DNA was detected by
polymerase chain reaction (PCR) analysis and Epstein-Barr
virus in situ hybridization was negative. The pathologic diag-
nosis was Castleman disease, plasma cell type. 
An autopsy was performed eight hours postmortem. The
skin and sclera were bright yellow in color. There were mul-
tiple enlarged lymph nodes (up to 1.3 cm in diameter) in the
neck, mediastinum, abdominal cavity, axilla, and inguinal
area. Microscopically, the nodal architecture was diffusely eff-
aced with paracortical hyperplasia with burnt-out lymphoid
follicles. Plasma cells and plasmacytoid cells were increased
in the paracortical area. In addition, many hemophagocytic
histiocytes diffusely infiltrated the sinus (Fig. 2A). Some of
the immunoblastic cells, putative B cells, were positive for
KSHV (HHV-8) latent nuclear antigen 1 (LANA-1; Fig. 2B)
based on immunohistochemistry and KSHV DNA was de-
tected in PCR analysis. These findings strongly suggested
KSHV-associated hemophagocytic syndrome. 
Small erosions and nodules <1 cm were found in the gas-
tric mucosa (Fig. 2C), in the lung parenchyma, and in the
pericolic fat tissue. They were composed of intersecting spin-
dle cells with extravasated RBCs and a few mitotic figures
(3/10HPF; Fig. 2D). The spindle cells immuno-stained for
CD31, factor VIII, vimentin, and KSHV (HHV-8) LANA-
1, and KSHV DNA was detected by PCR (Fig. 3). There-
fore, the lesions were diagnosed as Kaposi sarcoma. The spleen
was enlarged (810 g) with multifocal infarctions. Microscop-
ically, the plasma cells were markedly increased in the red and
white pulp with some hemosiderin-laden macrophages. The
liver was mildly enlarged (2,320 g), and showed features of
Fig. 1. Histologic features of initial lymph node biopsy specimen. (A) At low magnification, lymphoid follicular hyperplasia was observed
with preserved nodal architecture (H&E, ×12.5). (B) Plasma cells were markedly increased in the interfollicular area (H&E, ×200).
A Bnon-specific hypoxic damage, including periportal fibrosis
and minimal portal inflammation. KSHV DNA was also de-
tected in the liver and spleen (Fig. 3). Acute tubular necro-
sis was focally observed in the kidney. The heart had lumi-
nal narrowing with atherosclerosis in the anterior descend-
ing, right circumflex, and right coronary arteries. Sclerotic
acellular scarring, patch fibrosis, and degeneration of myo-
fibers suggested chronic ischemia and hypertensive heart dis-
ease. In the bone marrow from the vertebra, a few hemopha-
gocytic histiocytes and increased plasma cells were noted. 
DISCUSSION
Hemophagocytic syndrome is associated with variable sys-
temic diseases, including viral infections, as represented by
the Epstein-Barr virus (EBV) (7, 8). Most of the KSHV-asso-
ciated hemophagocytic syndromes have been reported in im-
munocompromised hosts, with few reports in immunocom-
petent patients (6, 9). Li et al. (6), for the first time, reported
a case of KSHV-associated hemophagocytic syndrome in a
HIV-negative, immunocompetent host with MCD. Re et al.
(9) described two additional cases in HIV-negative, non-trans-
plant patients. Our patient had no history suggesting immune
deficiency before the diagnosis of Castleman disease. Although
he had diabetes mellitus, it was detected only three months
previously and had been well controlled by oral hypoglycemic
agents. It is improbable that the short-term administration
of prednisolone for the management of Castleman disease
resulted in severe immunosuppression. The major clinico-
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Fig. 2. Pathologic features of the lymph nodes and stomach at autopsy. (A) In lymph node sinuses, many macrophages engulfing red blood
cells (hemophagocytic histiocytes) were observed (H&E, ×1,000). (B) A few LANA-1-positive lymphocytes were identified (LANA-1 immunos-
tain, ×400). (C) Within the gastric mucosa, a few erosions were found in the body. (D) Microscopically, the lesion was composed of spin-
dle-shaped endothelial cells with nuclear atypism and mitoses. Many extravasated RBCs were also observed (H&E, ×400).
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Fig. 3. PCR analysis for KSHV. KSHV DNA was detected in the liver
(lane 5), spleen (lane 6), stomach (lane 7), lung (lane 8), and lymph
nodes (lanes 11 and 12). (Lanes 1 and 2; positive control, lanes 3
and 4; negative control, lane 6; bone marrow, and lane 9; the con-
tralateral lung).KSHV-associated Hemophagocytic Syndrome in an Immunocompetent Host 973
pathologic features of the reported and present cases with
KSHV-associated hemophagocytic syndrome in immuno-
competent patients are summarized in Table 1. Notably, all
four of the patients followed a rapid and fatal clinical course,
and two of the patients also had MCD. All of them appeared
in old age. The concurrence of KS and Castleman disease of
the plasma cell type in this case further demonstrates that
the hemophagocytic syndrome could occur as a fatal compli-
cation of KSHV-related disease, even in HIV-negative and
non-transplant immunocompetent hosts. KSHV-associated
hemophagocytic syndrome has been reported to co-occur with
KSHV infection related diseases such as Kaposi sarcoma, mul-
ticentric Castleman disease or plasma effusion lymphoma in
immunocompromised host. This is the first case of multiple
KSHV associated diseases including MDC and KS with KS-
HV-associated hemophagocytic syndrome in an HIV-nega-
tive, non-transplant, immunocompetent patient. We thought
that our patients died of DIC and renal failure complicated
by severe hemophagocytic syndrome.
In the pathogenesis of the hemophagocytic syndrome, many
cytokines, including IFN-δ , IL-6, IL-10, and IL-12, are known
to be important (7). In the case of KHSV-related hemophago-
cytic syndrome, direct infection of monocytes by KSHV or
a paracrine influence from virus reactivation in reservoir cells
has been suggested as a possible pathogenetic mechanism (4).
Li et al. (6) speculated that proliferation of KSHV-infected
plasmablasts might have resulted in a cytokine storm, lead-
ing to virus-associated hemophagocytic syndrome similar to
EBV-associated T cell lymphoproliferative disorder.
IL-6 is known as a key cytokine involved in the pathogen-
esis of KSHV-associated diseases (7). IL-6 is a multipotent
cytokine having multiple biologic activities, including pro-
motion of B cell proliferation and differentiation with plas-
macytosis, stimulation of inflammatory pathways, and induc-
tion of B cell malignancies (10). KSHV encodes a viral homo-
logue of IL-6 (vIL-6), which can functionally mimic human
IL-6 and also induce the production of human IL-6 (10). In
a murine model, deregulated expression of IL-6 brought about
MCD-like features, including splenomegaly, extensive plas-
ma cell infiltration of the lymphoreticular system, and poly-
clonal hypergammaglobulinemia (11). Patients with Castle-
man disease of the plasma cell type have elevated serum IL-
6 levels (12). vIL-6 also induces vascular endothelial growth
factor (VEGF), and induces local tissue damage and attract-
ed inflammatory cells (13, 14). Thalidomide, a powerful anti-
cytokine effector, has been used for resolution of the systemic
manifestations of MCD (10). Recently, humanized anti-IL-
6 receptor antibody (tocilizumab) has proven to be useful for
the treatment of MCD (15). Although IL-6 was not evalu-
ated in our case, the presence of abundant plasmacytoid or
plasma cells in the lymph nodes and spleen, and T cell pro-
liferation in the bone marrow, suggest that IL-6 might play
an important role in disease progression and the hemophago-
cytic syndrome. Therefore, the present case emphasizes the
consideration of anti-IL-6 therapy for the management of po-
tentially fatal complication including hemophagocytic syn-
drome in MCD patients. 
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